Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
V335774-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $59.90 | |
V335774-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $149.90 | |
V335774-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $219.90 | |
V335774-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $369.90 | |
V335774-50mg | 50mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $539.90 | |
V335774-100mg | 100mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $749.90 |
a chemotherapy drug used to treat cancer
Synonyms | Valrubicin|56124-62-0|Valstar|AD-32|Antibiotic AD 32|Valstar Preservative Free|AD 32|NSC-246131|UNII-2C6NUM6878|N-Trifluoroacetyldoxorubicin 14-valerate|DTXSID9046497|HSDB 7288|2C6NUM6878|Valrubicin (AD-32)|N-Trifluoroacetyladriamycin-14-valerate|NSC 2461 |
---|---|
Biochemical and Physiological Mechanisms | Valrubicin is a semisynthetic derivative of the antineoplastic anthracycline antibiotic doxorubicin. Valrubicin is converted intracytoplasmically into N-trifluoroacetyladriamycin, which interacts with topoisomerase II, stabilizing the complex between the |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Action Type | INHIBITOR |
Mechanism of action | DNA inhibitor |
Product Description | Valrubicin is a chemotherapy drug used to treat cancer of the bladder. |
ALogP | 4 |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | [2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-4-[(2R,4S,5S,6S)-5-hydroxy-6-methyl-4-[(2,2,2-trifluoroacetyl)amino]oxan-2-yl]oxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethyl] pentanoate |
---|---|
INCHI | InChI=1S/C34H36F3NO13/c1-4-5-9-21(40)49-13-20(39)33(47)11-16-24(19(12-33)51-22-10-17(27(41)14(2)50-22)38-32(46)34(35,36)37)31(45)26-25(29(16)43)28(42)15-7-6-8-18(48-3)23(15)30(26)44/h6-8,14,17,19,22,27,41,43,45,47H,4-5,9-13H2,1-3H3,(H,38,46)/t14-,17-,19-,22-,27+,33-/m0/s1 |
InChi Key | ZOCKGBMQLCSHFP-KQRAQHLDSA-N |
Canonical SMILES | CCCCC(=O)OCC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)OC5CC(C(C(O5)C)O)NC(=O)C(F)(F)F)O |
Isomeric SMILES | CCCCC(=O)OCC(=O)[C@]1(C[C@@H](C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)NC(=O)C(F)(F)F)O |
PubChem CID | 454216 |
Molecular Weight | 723.64 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
D2419171 | Certificate of Analysis | Feb 04, 2024 | V335774 |
D2419172 | Certificate of Analysis | Feb 04, 2024 | V335774 |
D2419247 | Certificate of Analysis | Feb 04, 2024 | V335774 |
D2419248 | Certificate of Analysis | Feb 04, 2024 | V335774 |
D2419249 | Certificate of Analysis | Feb 04, 2024 | V335774 |
D2419250 | Certificate of Analysis | Feb 04, 2024 | V335774 |
D2419251 | Certificate of Analysis | Feb 04, 2024 | V335774 |
D2419252 | Certificate of Analysis | Feb 04, 2024 | V335774 |
D2419254 | Certificate of Analysis | Feb 04, 2024 | V335774 |
D2419255 | Certificate of Analysis | Feb 04, 2024 | V335774 |
D2419387 | Certificate of Analysis | Feb 04, 2024 | V335774 |
D2419388 | Certificate of Analysis | Feb 04, 2024 | V335774 |
Solubility | Soluble in DMSO, and methanol. |
---|---|
Melt Point(°C) | 202-205° C |
Pictogram(s) | GHS06, GHS08, GHS07 |
---|---|
Signal | Danger |
Hazard Statements | H301:Toxic if swallowed H351:Suspected of causing cancer H312:Harmful in contact with skin H332:Harmful if inhaled H360:May damage fertility or the unborn child H340:May cause genetic defects H350:May cause cancer H361:Suspected of damaging fertility or the unborn child |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P281:Use personal protective equipment as required. P271:Use only outdoors or in a well-ventilated area. P270:Do not eat, drink or smoke when using this product. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P362+P364:Take off contaminated clothing and wash it before reuse. P330:Rinse mouth. P203:Obtain, read and follow all safety instructions before use. P301+P316:IF SWALLOWED: Get emergency medical help immediately. P318:if exposed or concerned, get medical advice. P317:Get emergency medical help. |